14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session III : Protein kinase cascades as therapeutic targets Poster III, 27<br />

Signal transduction pathway of CNP-dependent inhibition of upregulation of PAI-1<br />

expression by TNF-alpha in endothelial cells<br />

Hanna Jerczynska, Czeslaw Cierniewski, Zofia Pawlowska<br />

Department of Molecular & Medical Biophysics, Medical University in Lodz, Pol<strong>and</strong>. Email:<br />

pawlow@zdn.am.lodz.pl<br />

Plasminogen activator inhibitor type 1 (PAI-1) plays a fundamental role in regulation of the<br />

fibrinolytic system. PAI-1 synthesis is upregulated by multiple factors, but only few are<br />

known to be able to decrease PAI-1 expression. In <strong>our</strong> previous study we found that C-type<br />

natriuretic peptide (CNP), which modulates salt <strong>and</strong> water balance as well as vascular tone,<br />

was an effective inhibitor of PAI-1 synthesis <strong>and</strong> release from endothelial cells, it also reveals<br />

stronger inhibitory activity for TNF-alpha - stimulated cells. The <strong>signaling</strong> pathways required<br />

for this effect have not been elucidated. It was reported that NF-kB is involved in TNFregulated<br />

PAI-1 production. We have evidenced that the activation of MAPK kinase cascade<br />

is a necessary step in induction of PAI-1 expression by TNF in endothelial cells. In this study,<br />

the effects of signal transduction inhibitors on TNF-induced PAI-1 expression in the presence<br />

of CNP were examined. We used PD 98059, an ERK1/2 inhibitor, LY 294002, a PI3K/Akt<br />

inhibitor, <strong>and</strong> 8-bromo-cGMP, a soluble analog of cGMP to characterize the signal<br />

transduction pathway involved in CNP action in human endothelial cells. Involvement of NFkB<br />

activation in this process was also investigated.<br />

Our results imply that CNP inhibition of TNF-activated PAI-1 gene expression takes place via<br />

regulation of signal transduction pathways involving PI3K/Akt <strong>and</strong> cGMP-dependent protein<br />

kinase, possibly by inhibiting NF-kB-dependent pathways. The activation of ERK seems not<br />

to be implicated in this process. Thus, <strong>our</strong> results explain at least in part the mechanism<br />

involved in PAI-1 expression inhibition by CNP in TNF-stimulated endothelial cells.<br />

Supported by grants: QLK3-CT-2002-30326 (5th EU FP) <strong>and</strong> Medical University of Lodz,<br />

Pol<strong>and</strong>.<br />

- 213 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!